Skip to main content Skip to footer

Move beyond compliance to drive growth.

Pharmacovigilance (PV) unlocks growth potential when intelligence is integrated across the entire value chain.
Cognizant’s pharmacovigilance solutions help some of the world’s leading pharmaceutical companies collect and integrate safety data from numerous sources, in real time, while ensuring patient safety and compliance. But to drive additional revenue, businesses must leverage advanced cognitive technologies and analytics across the PV process to enable staff to better predict and reduce risks, discover new indications and expand drug development.​
Our team can help identify gaps in your pharmacovigilance processes and implement strategies to resolve them. Plus, we can help you select and implement the most advanced and appropriate digital technologies, such as artificial intelligence (AI), analytics, blockchain and cloud solutions that can transform pharmacovigilance from a necessary task to a growth enabler.
Learn more about our Life Sciences solutions for your business.
Digital operations services
Digital operations services

Cognizant’s digital operations can help you quickly scale patient safety processes across geographies and manage change, leaving your team to focus on high-value business contributions.

Business consulting services
Business consulting services

Services include best practices for cutting drug discovery costs, the latest requirements for risk management, and pharmacovigilance roadmaps for short-term gap analysis and long-term strategy.

IT integration services
IT integration services

Cognizant can help you find the most appropriate commercial off-the-shelf (COTS) and custom digital solutions across the entire product safety value chain.

Prebuilt frameworks
Prebuilt frameworks

Our solution accelerators generate faster results, assessing processes, evaluating safety analytics and leveraging a process transition model to tap the best, most cost-effective resources.

Pharmacovigilance considerations for biologics and biosimilars

This article explores the various aspects of safety monitoring and risk management for biologics and biosimilar pharmaceutical products. Given the complexity of these products, robust pharmacovigilance (PV) strategies are crucial for ensuring patient safety.

Pharmacovigilance PDF image
Pharmacovigilance and Complaint Management Operations—Services PEAK Matrix Assessment 2021

Everest Group recently ranked Cognizant as the industry leader in its 2021 Pharmacovigilance and Complaint Management Operations Services PEAK Matrix® Assessment, recognizing our market impact, vision and capabilities.

Everest Group


Gaurav Marya

Strategic Business Unit Head & Business Unit Integration Lead, Life Sciences

Take the first step

Serving customers by looking forward as well as back is a big promise, but the power of today’s new digital capabilities is vast and growing.

Let’s talk about how digital can work for your business.